Cargando…
Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and invasive malignant tumors in the world. The change in DNA methylation is a key event in HCC. METHODS: Methylation datasets for HCC and 17 other types of cancer were downloaded from The Cancer Genome Atlas (TCGA). The CpG sites...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214801/ https://www.ncbi.nlm.nih.gov/pubmed/34147096 http://dx.doi.org/10.1186/s12920-021-01015-9 |